Market Overview

UPDATE: Argus Research Upgrades Stryker

Related SYK
8 Biggest Price Target Changes For Tuesday
Earnings Scheduled For April 26, 2018

In their Wednesday morning summary, Argus Research analysts upgraded shares of Stryker (NYSE: SYK) from Hold to Buy and set a price target of $102.

Looking at 2014, the Argus team is forecasting a stronger second half for Stryker. The team is basing this on the company's "solid" growth in businesses outside orthopedics, a better position to boost sales of knee implants following the MAKO acquisition and a higher amount of elective surgeries.

The team also noted that the pending merger of Zimmer and Biomet may create a possibility for Stryker to gain market share due potential disruptions of the competitor's sales.

Based on the items above, the analysts at Argus have raised their EPS estimates from $4.78 to $4.81 and $5.06 to $5.20 for 2014 and 2015, respectively.

Latest Ratings for SYK

May 2018CitigroupMaintainsNeutralNeutral
Apr 2018Canaccord GenuityMaintainsBuyBuy
Apr 2018Stifel NicolausMaintainsBuyBuy

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Argus ResearchAnalyst Color News Upgrades Price Target Analyst Ratings


Related Articles (SYK + ZMH)

View Comments and Join the Discussion!